[Efficacy of catalin eyed drops in age-related cataract agents].
The present investigation studied the efficacy of Catalin eye drops (Senju Pharmaceutical Co, Osaka, Japan) in patients with early senile cataract. An objective procedure for the densitometric analysis of lens transparency images with a Pentacam apparatus (Oculus GmbH, Germany) was used to assess the results of the investigation. Unlike the control group, the patients using Catalin had a lower optical density in the anterior and posterior cortical lens layers and beneath the posterior capsule in the first months of therapy. In the other lens layers, the transparency remained unchanged whereas in the controls it was increased throughout the follow-up.
Polunin
G S
GS
Makarova
I A
IA
Bubnova
I A
IA
D000368:Aged; D000375:Aging; D002386:Cataract / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D003720:Densitometry; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007908:Lens, Crystalline / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D010078:Oxazines / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects
D009883:Ophthalmic Solutions; D010078:Oxazines; C004580:pirenoxine